<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0015">
 <label>Table 3</label>
 <caption>
  <p>Summary of the clinical trials of Convalescent Plasma for treatment of COVID-19.</p>
 </caption>
 <alt-text id="al0035">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center">Sr. no</th>
    <th align="center">Plasma intervention/treatment</th>
    <th align="center">Sponsor</th>
    <th align="center">Clinical phase (sample size)</th>
    <th align="center">Status</th>
    <th align="center">Clinical trial identifier</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>1.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">Hackensack Meridian Health, New Jersey, United States</td>
    <td align="center">Phase II
     <break/>(55)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04343755" id="ir0355" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04343755</ext-link>
    </td>
   </tr>
   <tr>
    <td>2.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">Erasmus Medical Center, Netherland</td>
    <td align="center">Phase II &amp; III
     <break/>(426)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04342182" id="ir0360" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04342182</ext-link>
    </td>
   </tr>
   <tr>
    <td>3.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">Cristina Avendaño Solá, Spain</td>
    <td align="center">Phase II
     <break/>(278)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04345523" id="ir0365" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04345523</ext-link>
    </td>
   </tr>
   <tr>
    <td>4.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">King Fahad Specialist Hospital Dammam,
     <break/>Saudi Arabia
     <break/>
    </td>
    <td align="center">Phase II
     <break/>(40)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04347681" id="ir0370" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04347681</ext-link>
    </td>
   </tr>
   <tr>
    <td>5.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">Centro de Hematología y Medicina Interna, Mexico</td>
    <td align="center">Phase II
     <break/>(10)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04357106" id="ir0375" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04357106</ext-link>
    </td>
   </tr>
   <tr>
    <td>6.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">University of Chicago, Illinois, United States</td>
    <td align="center">Phase I
     <break/>(10)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04340050" id="ir0380" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04340050</ext-link>
    </td>
   </tr>
   <tr>
    <td>7.</td>
    <td>Anti-SARS-CoV-2 Inactivated Convalescent Plasma recovered from COVID-19 Donors</td>
    <td align="center">Shanghai Public Health Clinical Center, Shanghai, China</td>
    <td align="center">Observational Study
     <break/>(15)
    </td>
    <td align="center">On-going</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04292340" id="ir0385" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04292340</ext-link>
    </td>
   </tr>
   <tr>
    <td>8.</td>
    <td>Convalescent Plasma from Recovered COVID-19 Donors</td>
    <td align="center">Institute of Liver and Biliary Sciences, New Delhi, India</td>
    <td align="center">Phase II
     <break/>(20)
    </td>
    <td align="center">Completed</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04346446" id="ir0390" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04346446</ext-link>
    </td>
   </tr>
   <tr>
    <td>9.</td>
    <td>Convalescent Plasma Therapy on Critically ill Novel Coronavirus (COVID-19) Patients</td>
    <td align="center">Alkarkh Health Directorate-Baghdad. Iraq</td>
    <td align="center">Interventional study
     <break/>(49)
    </td>
    <td align="center">Completed</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04441424" id="ir0395" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04441424</ext-link>
    </td>
   </tr>
   <tr>
    <td>10.</td>
    <td>Effectiveness of Convalescent Immune Plasma Therapy</td>
    <td align="center">Bagcilar Training and Research Hospital, Istanbul, Turkey</td>
    <td align="center">Interventional study
     <break/>(60)
    </td>
    <td align="center">Completed</td>
    <td align="center">
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04442958" id="ir0400" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04442958</ext-link>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
